#stomca

Latest posts tagged with #stomca on Bluesky

Trending

#MJF Tribute #WBC #Javier Bardem #Marty Supreme #Andrade #Jessie Buckley #Academy Awards #MBJ #Autumn Durald Arkapaw #Wallace #MJF Tribute #WBC #Javier Bardem #Marty Supreme #Andrade #Jessie Buckley #Academy Awards #MBJ #Autumn Durald Arkapaw #Wallace

Posts tagged #stomca

OncLive

@onclive.bsky.social

1 year ago

Comparable Survival Outcomes Observed With Atezolizumab/Bevacizumab vs Tremelimumab/Durvalumab in First-Line HCC Clinical outcomes did not significantly differ with atezolizumab plus bevacizumab vs tremelimumab and durvalumab in treatment-naive, unresectable HCC.

Comparable Survival Outcomes Observed With Atezolizumab/Bevacizumab vs Tremelimumab/Durvalumab in First-Line HCC @ascocancer.bsky.social #GI25 #stomca www.onclive.com/view/compara...

2 1 0 0

OncLive

@onclive.bsky.social

1 year ago

177Lu-edotreotide Improves PFS in Grade 1/2 GEP-NETs in Phase 3 COMPETE Trial 177Lu-edotreotide prolonged PFS vs everolimus in patients with inoperable, progressive, grade 1 or 2 gastroenteropancreatic neuroendocrine tumors.

177Lu-edotreotide Improves PFS in Grade 1/2 GEP-NETs in Phase 3 COMPETE Trial #stomca #pancsm #oncology www.onclive.com/view/177lu-e...

0 0 0 0

OncLive

@onclive.bsky.social

1 year ago

Evorpacept Plus TRP Generates Superior Antitumor Responses, Survival Outcomes in HER2+ Gastric/GEJ Cancer Evorpacept plus TRP produced superior ORR, DOR, and PFS outcomes vs TRP alone in patients with HER2-positive gastric or gastroesophageal junction cancer.

Evorpacept Plus TRP Generates Superior Antitumor Responses, Survival Outcomes in HER2+ Gastric/GEJ Cancer @ASCO #GI25 #stomca #oncology www.onclive.com/view/evorpac...

1 0 0 0

OncLive

@onclive.bsky.social

1 year ago

Nivolumab Plus Chemo Shows Long-Term OS Benefit in Chinese Patients With Advanced Gastric, GEJ, or Esophageal Cancer Nivolumab plus chemotherapy demonstrated long-term survival benefits in advanced gastric, GEJ, or esophageal cancer in China.

Nivolumab Plus Chemo Shows Long-Term OS Benefit in Chinese Patients With Advanced Gastric, GEJ, or Esophageal Cancer @ascocancer.bsky.social #GI25 #stomca #oncology www.onclive.com/view/nivolum...

1 1 0 0